Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Operating Expenses came in at $475.1 million in Q1 2026, up 27.45% year-on-year from $372.8 million in Q1 2025, and up 9.16% quarter-over-quarter from $435.2 million in Q4 2025.
Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Operating Expenses across 8 years of filings, most recently posting $475.1 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $475.1 million, up 27.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 36.78% YoY), and the FY2025 annual result was $1.6 billion, up 46.48% from the prior year.
- Operating Expenses came in at $475.1 million for Q1 2026 at Hims & Hers Health, up from $435.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $475.1 million in Q1 2026 to a low of $91.7 million in Q1 2022.
- The 5-year median for Operating Expenses is $219.2 million (2024), against an average of $260.9 million.
- Across the five-year window, Operating Expenses increased 3.41% in 2022 and jumped 79.64% in 2023, its largest moves.
- Hims & Hers Health's Operating Expenses stood at $143.9 million in 2022, then jumped by 42.04% to $204.5 million in 2023, then soared by 71.65% to $350.9 million in 2024, then advanced by 24.02% to $435.2 million in 2025, then advanced by 9.16% to $475.1 million in 2026.
- The last three Operating Expenses figures came in at $475.1 million (Q1 2026), $435.2 million (Q4 2025), and $430.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 475.11 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 96.91 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 71.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 475.11 Mn |
| Dec 31, 2025 | 435.25 Mn |
| Sep 30, 2025 | 430.25 Mn |
| Jun 30, 2025 | 389.47 Mn |
| Mar 31, 2025 | 372.79 Mn |
| Dec 31, 2024 | 350.95 Mn |
| Sep 30, 2024 | 295.51 Mn |
| Jun 30, 2024 | 245.58 Mn |
| Mar 31, 2024 | 219.19 Mn |
| Dec 31, 2023 | 204.46 Mn |
| Sep 30, 2023 | 195.86 Mn |
| Jun 30, 2023 | 179.39 Mn |
| Mar 31, 2023 | 164.69 Mn |
| Dec 31, 2022 | 143.94 Mn |
| Sep 30, 2022 | 134.44 Mn |
| Jun 30, 2022 | 107.37 Mn |
| Mar 31, 2022 | 91.68 Mn |
| Dec 31, 2021 | 83.66 Mn |
| Sep 30, 2021 | 82.53 Mn |
| Jun 30, 2021 | 64.68 Mn |